journal article·2014-02

Synthesis and carbonic anhydrase inhibitory properties of tetrazole- and oxadiazole substituted 1,4-dihydropyrimidinone compounds

Fatma Celik, Mustafa Arslan, Mustafa Oguzhan Kaya, Emre Yavuz, Nahit Gencer, Oktay Arslan

Publisher page

Abstract

A new series of tetrazole-, oxadiazole- and cyanosubstituted 1,4-dihydropyrimidinone compounds were synthesized, and their inhibitory effects on the activity of purified human carbonic anhydrase (hCA) I were evaluated. 4-Cyanophenyl-1,4-dihydropyrimidinone compounds were prepared with 1,3-diketone, cyanobenzaldehyde and urea. The compounds were reacted with sodium azide and then with anhydride to get the final products. The results showed that all the synthesized compounds inhibited the CA isoenzyme activity. The compound 4-(1,7,7-trimethyl-2,5-dioxo-1,2,3,4,5,6,7,8-octahydroquinazoline-4-yl)benzonitrile 6c (IC50 = 0.0547 mM) has the most inhibitory effect.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Synthesis of Tetrazole Derivatives · Quinazolinone synthesis and applications · Enzyme function and inhibition

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Arslan M · J Enzyme Inhib Med Chem · 2012 · 27 · 72210.3109/14756366.2011.611135 ↗
2. Arslan O · Turk J Med Sci · 1996 · 26 · 16310.55730/1300-0144.5146 ↗
3. Arslan O · Bioorg Med Chem · 1997 · 3 · 51510.1016/S0968-0896(96)00272-6 ↗
4. Aydemir T · Artif Cells Blood Substit Immobil Biotechnol · 2009 · 37 · 9210.1080/10731190902742489 ↗
5. Besoluk S · Turk J Chem · 2010 · 34 · 411
6. Besoluk S · J Iran Chem Soc · 2008 · 5 · 6210.1007/BF03245816 ↗
7. Biginelli P · Gazz Chem · 1893 · 23 · 360
8. 10.3109/10731199.2012.67894310.3109/10731199.2012.678943 ↗
9. Cicek B · Asian J Chem · 2012 · 24 · 3729
10. Demir D · Artif Cells Blood Substit Biotechnol · 2012 · 40 · 39110.3109/10731199.2012.696060 ↗
11. Demirel LAB · Artif Cells Blood Substit Immobil Biotechnol · 2004 · 32 · 60910.1081/BIO-200039654 ↗
12. Ekinci D · Europ J Med Chem · 2012 · 49 · 6810.1016/j.ejmech.2011.12.022 ↗
13. 10.3109/14756366.2011.58453510.3109/14756366.2011.584535 ↗
14. Gocke B · J Enzyme Inhib Med Chem · 2012 · 27 · 3710.3109/14756366.2011.574130 ↗
15. Gilmour KM · J Exp Biol · 2009 · 212 · 164710.1242/jeb.029181 ↗
16. 10.1021/jm200209n10.1021/jm200209n ↗
17. Herr RJ · Bioorg Med Chem · 2002 · 10 · 337910.1016/S0968-0896(02)00239-0 ↗
18. Ichikawa T · Chem Pharm Bull · 2001 · 49 · 111010.1248/cpb.49.1110 ↗
19. Kappe CO · Eur J Med Chem · 2000 · 35 · 104310.1016/S0223-5234(00)01189-2 ↗
20. Kappe CO · New tricks from an old dog. Accounts Chem Res · 2000 · 33 · 87910.1021/ar000048h ↗
21. Katritzky AR · J Org Chem · 2010 · 75 · 646810.1021/jo101195z ↗
22. Maren TH · J Pharm Exp Ther · 1960 · 130 · 2629
23. 10.1021/jm901287j10.1021/jm901287j ↗
24. 10.1021/ja809683v10.1021/ja809683v ↗
25. Maresca A · Bioorg Med Chem Lett · 2010 · 20 · 451110.1016/j.bmcl.2010.06.040 ↗
26. Ozensoy O · J Enzyme Inh Med Chem · 2008 · 23 · 57910.1080/14756360701731957 ↗
27. Patil UB · Tetrahedron Lett · 2012 · 53 · 370610.1016/j.tetlet.2012.04.093 ↗
28. Rafiee E · Bioorg Med Chem Lett · 2006 · 16 · 246310.1016/j.bmcl.2006.01.087 ↗
29. Rajasekaran A · Eur J Med Chem · 2004 · 39 · 27310.1016/j.ejmech.2003.11.016 ↗
30. Sabbah M · Bioorg Med Chem · 2012 · 20 · 472710.1016/j.bmc.2012.06.007 ↗
31. Sayin D · J Enzyme Inhib Med Chem · 2012 · 27 · 59510.3109/14756366.2011.604320 ↗
32. Snider BB · Revision of the stereochemistry of batzelladines A and D Tetrahedron Lett · 1996 · 37 · 697710.1016/0040-4039(96)01575-4 ↗
33. 10.4155/fmc.11.6910.4155/fmc.11.69 ↗
34. Supuran CT · Exp Opta Ther Patents · 2000 · 10 · 57510.1517/13543776.10.5.575 ↗
35. Supuran CT · Nature Rev Drug Discov · 2008 · 7 · 16810.1038/nrd2467 ↗
36. Waisser K · Chem Pap · 2004 · 58 · 214